Deep Genomics is using artificial intelligence to build a new universe of life-saving genetic therapies. The future of medicine will rely on artificial intelligence, because biology is too complex for humans to understand. At Deep Genomics, our geneticists, molecular biologists and chemists develop new ways of detecting and treating disease using our biologically accurate artificial intelligence technology.
B2C, B2B
26 to 50
Series B
$56.7M
Growth
2014
Pharmaceuticals
Drug Retail
Biotechnology
N/A
N/A
Yes
Active
Machine Learning
Natural Language Processing
N/A
Software
Potential Customers
Interested in what they do or partnership?
Learn more about how they work